DEHP metabolites and mono-3-carboxypropyl phthalate (MCPP) have been linked to higher concentrations of serum pregnancy-associated plasma protein A (PAPP-A), a marker of placental function that is elevated in individuals with pregnancy-induced hypertension (PIH) [21], and urinary DEHP metabolites are inversely associated with maternal serum placental growth factor (PlGF), a biomarker of angiogenesis and, indirectly, placental function [21,22,23,24]. The gene discussed is PGF; the disease is hypertension, pregnancy-induced.